bpc-157 human clinical trial injection near injury site evidence Peptide BPC-157 & The Gut-Brain Axis:

An analysis of six clinical trials found that AOD 9604 had a safety profile comparable to placebo and did not act through the IGF-1 pathway

While flow cytometry and bone marrow biopsy were considered necessary to definitively rule out these conditions, further non-invasive workups were conducted first to narrow down the diagnosis and confirm the underlying etiology while patients received Pantoprazole, fluid, and two units of packed RBCs

In routine microscopy of urine, no red blood cells were detected, and the urine culture report was sterile

Breastfeeding Cyanocobalamin is excreted in the breast milk of nursing women in levels similar to the level of vitamin B12 in maternal plasma (18)

Similarly, women who are breastfeeding should avoid NAD+ injections, since it is unknown whether the exogenous NAD+ could affect the nursing infant or alter milk composition